4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-17-000007
CIK 0000899866operating
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:21 PM ET
Size
20.4 KB
Accession
0000899866-17-000007
Insider Transaction Report
Form 4
BELL LEONARD
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock, par value $.0001 per share
2017-01-05$22.90/sh+34,210$783,409→ 438,497 total - Sale
Common Stock, par value $.0001 per share
2017-01-05$135.07/sh−17,105$2,310,372→ 421,392 total - Sale
Common Stock, par value $.0001 per share
2017-01-05$134.90/sh−334$45,057→ 403,953 total(indirect: By Trust) - Sale
Common Stock, par value $.0001 per share
2017-01-09$144.93/sh−4,853$703,345→ 403,619 total - Exercise/Conversion
Option to Purchase Common Stock
2017-01-05−34,210→ 81,791 totalExercise: $22.90From: 2010-04-28Exp: 2020-01-28→ Common Stock, par value $.0001 per share (34,210 underlying) - Exercise/Conversion
Option to Purchase Common Stock
2017-01-09−4,853→ 76,938 totalExercise: $22.90From: 2010-04-28Exp: 2020-01-28→ Common Stock, par value $.0001 per share (4,853 underlying) - Sale
Common Stock, par value $.0001 per share
2017-01-05$139.90/sh−334$46,727→ 403,619 total(indirect: By Trust) - Exercise/Conversion
Common Stock, par value $.0001 per share
2017-01-09$22.90/sh+4,853$111,134→ 408,472 total - Sale
Common Stock, par value $.0001 per share
2017-01-09$144.90/sh−334$48,397→ 403,285 total(indirect: By Trust) - Sale
Common Stock, par value $.0001 per share
2017-01-05$139.98/sh−17,105$2,394,358→ 404,287 total
Footnotes (4)
- [F1]This transaction is made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $134.90 - $135.90. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $139.90 - $140.90. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F4]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $144.90 - $145.89. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:21 PM ET
- Size
- 20.4 KB